THYROID HORMONE ACTION IN THYROTROPIC CELLS

促甲状腺细胞中的甲状腺激素作用

基本信息

项目摘要

The proposed research involves defining the detailed molecular mechanisms by which thyrotropin-releasing hormone (TRH, thyroliberin) stimulates the secretion (release of preformed hormone) of thyrotropin (thyroid-stimulting hormone, TSH) and prolactin (PRL) from the anterior pituitary gland. Two homogeneous populations of pituitary cells are used in these studies so that one may unambiguously assign changes in various aspects of cellular calcium homeostasis to the appropriate cell type. These are a mouse (LAF1/J) thyrotropic pituitary tumor from which cells are derived for short-term studies in culture (TtT cells) and a cloned cell line (GH3 cells) originally derived from a rat mammotropic pituitary tumor. Some comparative studies in which measurement only of TSH and PRL are made will be performed in vitro using cells derived from normal female Sprague-Dawley rats. It has recently been demonstrated that TRH causes a rapid elevation of cytoplasmic free Ca2+ concentration ([Ca2+])i and it has been proposed that this increase in [Ca2+]i serves to couple, at least in part, stimulation by TRH to secretion of TSH and PRL. In this proposal, further studies of the effects of TRH on [Ca2+]i will be made and additive, synergistic and/or antagonistic effects of other regulators of TSH and PRL secretion will be determined. The cellular pools of calcium mobilized by TRH will be determined in intact and detergent-permeabilized cells. A possible second messenger fuction if inositoltrisphosphate in TRH mobilization of cellular calcium and the mechanism of inositoltrisphosphate action will be studied in detergent-permeabilized cells and in isolated cellular organelles. Lastly, studies will be made of secretagogues, such as arachidonic acid and phorbol esters, that appear to act without causing an elevation of [Ca2+]i. The additivity or synergism of stimulation of secretion by arachidonic acid and phorbol esters with secretagogues tht act via elevating [Ca2+]i will be studied as will their effects on cellular calcium homeostasis. It is believed that a more complete understanding of how TRH acts will serve to expand our understanding of the mechanism of action of many cell-surface interacting regulators and allow us to understand better some pathologic conditions that involve abnormalities in cell regulation.
建议的研究包括定义详细的分子机制。 促甲状腺激素释放激素(TRH、促甲状腺激素)通过何种途径刺激 促甲状腺激素(促甲状腺激素)的分泌(前形成激素的释放) 激素(激素,TSH)和催乳素(PRL)。二 在这些研究中使用了同质的垂体细胞群,因此 一个人可以毫不含糊地将细胞的各个方面的变化 钙平衡到适当的细胞类型。这些是一只老鼠 (LAF1/J)甲状腺垂体瘤,细胞来源于 培养(TTT细胞)和克隆细胞系(GH3)的短期研究 细胞)最初来自于大鼠的嗜乳性脑垂体瘤。一些人 只测量TSH和PRL的比较研究将 用取自正常女性的细胞进行体外实验 老鼠。最近的研究表明,促肾上腺皮质激素释放激素会导致血压迅速升高。 胞质内游离钙浓度([Ca~(2+)])i的变化,并提出了 这种[Ca~(2+)]i的增加至少在一定程度上与 TRH对TSH和PRL分泌的刺激作用。在这项提案中,进一步 TRH对[Ca~(2+)]i的影响的研究将被进行和添加, 促甲状腺激素和催乳素其他调节剂的协同和/或拮抗作用 分泌物将会被确定。细胞内钙离子池的动员 TRH将在完整和洗涤剂渗透的细胞中进行测定。一个 肌醇三磷酸在TRH中可能的第二信使功能 细胞内钙的动员与三磷酸肌醇的作用机制 将在洗涤剂渗透性细胞中和在分离的 细胞器。最后,将对分泌物进行研究,如 如花生四烯酸和佛波醇酯,它们似乎不会引起 [Ca~(2+)]的升高I.刺激的相加性或协同性 花生四烯酸和佛波酯与促分泌剂的分泌 通过升高[Ca~(2+)]i来研究它们对细胞的影响 钙稳态。人们相信,更全面地了解 TRH的作用机制将有助于扩大我们对 许多细胞表面相互作用的调节因子的作用,并允许我们 更好地了解一些涉及心脏异常的病理情况 细胞调节。

项目成果

期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ca2+ ionophores affect phosphoinositide metabolism differently than thyrotropin-releasing hormone in GH3 pituitary cells.
Ca2 离子载体对 GH3 垂体细胞中磷酸肌醇代谢的影响与促甲状腺素释放激素不同。
Thyrotropin-releasing hormone action: mechanism of calcium-mediated stimulation of prolactin secretion.
促甲状腺激素释放激素作用:钙介导刺激催乳素分泌的机制。
Evidence for tight coupling of thyrotropin-releasing hormone receptors to stimulated inositol trisphosphate formation in rat pituitary cells.
促甲状腺激素释放激素受体与刺激大鼠垂体细胞中三磷酸肌醇形成紧密耦合的证据。
Mechanism of thyrotropin releasing hormone stimulation of pituitary hormone secretion.
促甲状腺激素释放激素刺激垂体激素分泌的机制。
  • DOI:
    10.1146/annurev.ph.48.030186.002503
  • 发表时间:
    1986
  • 期刊:
  • 影响因子:
    18.2
  • 作者:
    Gershengorn,MC
  • 通讯作者:
    Gershengorn,MC
Evidence for tight coupling of receptor occupancy by thyrotropin-releasing hormone to phospholipase C-mediated phosphoinositide hydrolysis in rat pituitary cells: use of chlordiazepoxide as a competitive antagonist.
大鼠垂体细胞中促甲状腺素释放激素受体占据与磷脂酶 C 介导的磷酸肌醇水解紧密耦合的证据:使用利眠宁作为竞争性拮抗剂。
  • DOI:
    10.1210/endo-119-2-833
  • 发表时间:
    1986
  • 期刊:
  • 影响因子:
    4.8
  • 作者:
    Gershengorn,MC;Paul,ME
  • 通讯作者:
    Paul,ME
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARVIN C GERSHENGORN其他文献

MARVIN C GERSHENGORN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARVIN C GERSHENGORN', 18)}}的其他基金

BIOLOGY OF HHV8/KSHV G PROTEIN COUPLED RECEPTOR
HHV8/KSHV G 蛋白偶联受体的生物学
  • 批准号:
    2653230
  • 财政年份:
    1998
  • 资助金额:
    $ 18.31万
  • 项目类别:
BIOLOGY OF HHV8/KSHV G PROTEIN COUPLED RECEPTOR
HHV8/KSHV G 蛋白偶联受体的生物学
  • 批准号:
    2882491
  • 财政年份:
    1998
  • 资助金额:
    $ 18.31万
  • 项目类别:
DYNORPHIN AND BETA CELL SENSITIZATION
强啡肽和 β 细胞致敏
  • 批准号:
    2794817
  • 财政年份:
    1998
  • 资助金额:
    $ 18.31万
  • 项目类别:
DYNORPHIN AND BETA CELL SENSITIZATION
强啡肽和 β 细胞致敏
  • 批准号:
    2906354
  • 财政年份:
    1998
  • 资助金额:
    $ 18.31万
  • 项目类别:
THYROTROPIN RELEASING HORMONE RECEPTOR MOLECULAR BIOLOGY
促甲状腺素释放激素受体分子生物学
  • 批准号:
    2824954
  • 财政年份:
    1998
  • 资助金额:
    $ 18.31万
  • 项目类别:
BIOLOGY OF HHV8/KSHV G PROTEIN COUPLED RECEPTOR
HHV8/KSHV G 蛋白偶联受体的生物学
  • 批准号:
    6164248
  • 财政年份:
    1998
  • 资助金额:
    $ 18.31万
  • 项目类别:
DESENSITIZATION OF CALCIOTROPIC HORMONE RECEPTORS
促钙激素受体脱敏
  • 批准号:
    2145925
  • 财政年份:
    1993
  • 资助金额:
    $ 18.31万
  • 项目类别:
DESENSITIZATION OF CALCIOTROPIC HORMONE RECEPTORS
促钙激素受体脱敏
  • 批准号:
    2145923
  • 财政年份:
    1993
  • 资助金额:
    $ 18.31万
  • 项目类别:
DESENSITIZATION OF CALCIOTROPIC HORMONE RECEPTORS
促钙激素受体脱敏
  • 批准号:
    3248057
  • 财政年份:
    1993
  • 资助金额:
    $ 18.31万
  • 项目类别:
DESENSITIZATION OF CALCIOTROPIC HORMONE RECEPTORS
促钙激素受体脱敏
  • 批准号:
    2145924
  • 财政年份:
    1993
  • 资助金额:
    $ 18.31万
  • 项目类别:

相似海外基金

Endocrinological crosstalk between aldosterone-related hypertension and calcium metabolism
醛固酮相关高血压与钙代谢之间的内分泌串扰
  • 批准号:
    19K17974
  • 财政年份:
    2019
  • 资助金额:
    $ 18.31万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
study of the intestinal sensing of food elements - autonomy absorption mechanism to produce robust characteristics of the calcium metabolism
研究肠道对食物元素的感知 - 自主吸收机制以产生强大的钙代谢特征
  • 批准号:
    17H01967
  • 财政年份:
    2017
  • 资助金额:
    $ 18.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The roles of vitamin D dependent novel phosphate sensing-system on calcium metabolism and local calcification.
维生素 D 依赖性新型磷酸盐传感系统对钙代谢和局部钙化的作用。
  • 批准号:
    26462816
  • 财政年份:
    2014
  • 资助金额:
    $ 18.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Effects of Exercise on Bone and Phosphorus and Calcium Metabolism in Phosphorus Enriched Diets
运动对富磷饮食中骨骼和磷、钙代谢的影响
  • 批准号:
    26350916
  • 财政年份:
    2014
  • 资助金额:
    $ 18.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The actions of the hormone, calcitonin, on bone and calcium metabolism.
激素降钙素对骨骼和钙代谢的作用。
  • 批准号:
    nhmrc : GNT1058189
  • 财政年份:
    2014
  • 资助金额:
    $ 18.31万
  • 项目类别:
    Project Grants
Establishment of new visualization methods for calcium metabolism disorders and fibrosis in chronic kidney disease
建立慢性肾脏病钙代谢紊乱和纤维化的新可视化方法
  • 批准号:
    24591237
  • 财政年份:
    2012
  • 资助金额:
    $ 18.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Effects of Gastric Bypass Surgery on Calcium Metabolism and the Skeleton
胃绕道手术对钙代谢和骨骼的影响
  • 批准号:
    8244951
  • 财政年份:
    2011
  • 资助金额:
    $ 18.31万
  • 项目类别:
Effects of Gastric Bypass Surgery on Calcium Metabolism and the Skeleton
胃绕道手术对钙代谢和骨骼的影响
  • 批准号:
    8142498
  • 财政年份:
    2011
  • 资助金额:
    $ 18.31万
  • 项目类别:
Effects of Gastric Bypass Surgery on Calcium Metabolism and the Skeleton
胃绕道手术对钙代谢和骨骼的影响
  • 批准号:
    8698385
  • 财政年份:
    2011
  • 资助金额:
    $ 18.31万
  • 项目类别:
Effects of Gastric Bypass Surgery on Calcium Metabolism and the Skeleton
胃绕道手术对钙代谢和骨骼的影响
  • 批准号:
    8793739
  • 财政年份:
    2011
  • 资助金额:
    $ 18.31万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了